InsidersTradesSigma
Follow the タカラバイオ株式会社 stock price and the full insider trade history of the company, a listed equity based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). The latest transaction was disclosed on 21 April 2026 (Holding update). Among the most active insiders: Nomura Asset Management Co., Ltd.. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Takara Bio Inc. is a Japanese biotechnology company that provides products and services in research and development. It is listed on the Tokyo Stock Exchange under the symbol XTKS.